Skip to menu Skip to content Skip to footer

Preclinical development of combinations with CHK1 inhibitors in melanoma and lung cancer (2018-2019)

Experts

Professor Brian Gabrielli

Honorary Professor
Mater Research Institute-UQ
Faculty of Medicine
Brian Gabrielli
Brian Gabrielli